-
Abbott to acquire Cerevel and its neuroscience pipeline
On December 7th, Abbey and Cerevel Therapeutics announced a final agreement - Abbey will acquire Cerevel Therapeutics and its neuroscience pipeline. Cerevel's pipeline consists of multiple clinical s ... -
Tianjing Biotechnology management welcomes another 'major overhaul': the shadow of CD47 target failure still lingers in the innovation pipeline with only three remaining CD47 targets
On July 15th, IMAB. US announced that its board of directors has appointed Fu Wei as the chairman of the board. Fu Wei will replace Pamela M. Klein, who will step down as director and interim chairma ... -
Bristol Myers Squibb regains exclusive development and commercialization rights for RayzeBio pipeline products in the Greater China market
On December 19th, Bristol Myers Squibb announced that the company has reached an agreement with AbbVie Pharmaceuticals to regain exclusive rights to develop and commercialize ABZ-706 (equivalent to R ...